192 related articles for article (PubMed ID: 8636449)
1. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.
Salmon JE; Millard S; Schachter LA; Arnett FC; Ginzler EM; Gourley MF; Ramsey-Goldman R; Peterson MG; Kimberly RP
J Clin Invest; 1996 Mar; 97(5):1348-54. PubMed ID: 8636449
[TBL] [Abstract][Full Text] [Related]
2. Association of FcγRIIA-R/H131 polymorphism and systemic lupus erythematosus lupus nephritis risk: A meta-analysis.
Xu Y; Wei HT; Zou JJ; Ma YR
Int J Rheum Dis; 2020 Jul; 23(7):853-867. PubMed ID: 32189478
[TBL] [Abstract][Full Text] [Related]
3. Value of HLA-DR genotype in systemic lupus erythematosus and lupus nephritis: a meta-analysis.
Niu Z; Zhang P; Tong Y
Int J Rheum Dis; 2015 Jan; 18(1):17-28. PubMed ID: 25546242
[TBL] [Abstract][Full Text] [Related]
4. Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis.
Tsang-A-Sjoe MW; Nagelkerke SQ; Bultink IE; Geissler J; Tanck MW; Tacke CE; Ellis JA; Zenz W; Bijl M; Berden JH; de Leeuw K; Derksen RH; Kuijpers TW; Voskuyl AE
Rheumatology (Oxford); 2016 May; 55(5):939-48. PubMed ID: 26748351
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis.
Friebus-Kardash J; Trendelenburg M; Eisenberger U; Ribi C; Chizzolini C; Huynh-Do U; Lang KS; Wilde B; Kribben A; Witzke O; Dolff S; Hardt C
BMC Nephrol; 2019 Nov; 20(1):430. PubMed ID: 31752784
[TBL] [Abstract][Full Text] [Related]
6. Fc gamma receptor polymorphisms in systemic lupus erythematosus and their correlation with the clinical severity of the disease.
Pradhan V; Patwardhan M; Ghosh K
Indian J Hum Genet; 2008 Sep; 14(3):77-81. PubMed ID: 20300300
[TBL] [Abstract][Full Text] [Related]
7. Fc gamma receptor IIIa polymorphism is not associated with susceptibility to systemic lupus erythematosus in Brazilian patients.
Grecco M; Santos VC; Pereira KM; Andrade LE; Silva NP
Rev Bras Reumatol Engl Ed; 2016; 56(6):515-520. PubMed ID: 27914599
[TBL] [Abstract][Full Text] [Related]
8. Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese.
Chen JY; Wang CM; Chen TD; Jan Wu YJ; Lin JC; Lu LY; Wu J
Arthritis Res Ther; 2018 Aug; 20(1):193. PubMed ID: 30157968
[TBL] [Abstract][Full Text] [Related]
9. Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up.
Gerhardsson J; Sundelin B; Zickert A; Padyukov L; Svenungsson E; Gunnarsson I
Arthritis Res Ther; 2015 Apr; 17(1):109. PubMed ID: 25927214
[TBL] [Abstract][Full Text] [Related]
10. Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation.
Deniz R; Ozen G; Yilmaz-Oner S; Alibaz-Oner F; Erzik C; Aydin SZ; Inanc N; Eren F; Bayalan F; Direskeneli H; Atagunduz P
Lupus; 2015 Jun; 24(7):705-11. PubMed ID: 25413357
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD64 on Surface of Circulating Monocytes in Systemic Lupus Erythematosus Patients: Relation to Disease Activity and Lupus Nephritis.
Abd-Elhamid YA; Eltanawy RM; Fawzy RM; Fouad NA; Atlm AM
Egypt J Immunol; 2017 Jan; 24(1):67-78. PubMed ID: 29120579
[TBL] [Abstract][Full Text] [Related]
12. Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies.
Siddiqi KZ; Wilhelm TR; Ulff-Møller CJ; Jacobsen S
Transl Res; 2021 Dec; 238():63-75. PubMed ID: 34343626
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation of FcγRIIa induces higher uptake of
Catarino JDS; de Oliveira RF; Silva MV; Sales-Campos H; de Vito FB; da Silva DAA; Naves LL; Oliveira CJF; Rodrigues DBR; Rodrigues V
Front Immunol; 2024; 15():1343602. PubMed ID: 38455048
[TBL] [Abstract][Full Text] [Related]
14. Delineating the Risk of Lupus Nephritis: How Far Have We Come?
Lee J
J Rheum Dis; 2021 Oct; 28(4):173-175. PubMed ID: 37476364
[No Abstract] [Full Text] [Related]
15. Living Donor Kidney Transplant in Recipients With Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes.
El-Rifai R; Bregman A; Klomjit N; Spong R; Jackson S; Nachman PH; Riad S
Transpl Int; 2023; 36():11068. PubMed ID: 37213488
[TBL] [Abstract][Full Text] [Related]
16. Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype.
Cornwell MG; Bannoudi HE; Luttrell-Williams E; Engel A; Barrett TJ; Myndzar K; Izmirly P; Belmont HM; Clancy R; Ruggles KV; Buyon JP; Berger JS
J Transl Med; 2023 Apr; 21(1):247. PubMed ID: 37029410
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes.
Frazzei G; van Vollenhoven RF; de Jong BA; Siegelaar SE; van Schaardenburg D
Front Immunol; 2022; 13():899372. PubMed ID: 35844538
[TBL] [Abstract][Full Text] [Related]
18. Immunogenetics of Lupus Erythematosus.
Ünlü B; Türsen Ü; Jabalameli N; Abdollahimajd F; Rajabi F
Adv Exp Med Biol; 2022; 1367():213-257. PubMed ID: 35286698
[TBL] [Abstract][Full Text] [Related]
19. Lupus-Mediated Kidney Damage: Lupus Nephritis or Collapsing Glomerulopathy?
De La Cruz A; Ghazanfar H; Peña N; Nasr R
Cureus; 2021 Apr; 13(4):e14468. PubMed ID: 33996327
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
